Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.
Saved in:
| Title: | Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice. |
|---|---|
| Authors: | Rinotas V; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Ntouskou ED; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Dragolia M; Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Ntafis V; Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece., Yavropoulou MP; Endocrinology Unit, 1st Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Anastasilakis AD; Department of Endocrinology, Diabetes and Metabolism, 424 General Military Hospital, Thessaloniki, Greece., Makras P; Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force, Veterans Affairs General Hospital, Athens, Greece., Douni E; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.; Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens, Greece. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Feb 26; Vol. 17, pp. 1783656. Date of Electronic Publication: 2026 Feb 26 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2026.1783656 |
